ninds

Nexeon MedSystems Receives $830,000 grant from the National Institute of Neurological Disorders and Stroke

Dallas, TX, Sept. 25, 2018 — Nexeon MedSystems Inc (”Nexeon”) (OTCQB: NXNN), a neurostimulation medical device company, announced that it has received an $830,000 grant from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH). The grant award, received through its wholly-owned subsidiary Nexeon MedSystems Puerto Rico Operations…